bpc 157 mechanism Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review Pentadecapeptide BPC 157 Enhances the

Description Additional information Description NAD+ (100mg) / MOTS-C (10mg) / 5-Amino-1MQ (10mg) Peptide Blend 120mg Total Vial **Important Information: Each peptide comes lyophilized/freeze-dried and must be reconstituted with Bacteriostatic Water in order to be dispensable in liquid form

RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)

For all dosages in one place, see the peptide dosage chart

The optimal dose and whether you need oral supplements or injections depend on the condition and your current B12 levels